Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Nasal Spray in Adolescent Smokers
NCT00625794Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2005
- Primary completion
- May 2007
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Self-reported smoking abstinence verified by both expired-air carbon monoxide and salivary cotinine at 12 weeks. Started Sep 2005; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00625794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625794.